NCT00630474View on ClinicalTrials.gov

Nasal Decongestion and Obstructive Sleep Apnea

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Obstructive Sleep Apnea SyndromeRhinitis
Interventions
DRUG

xylometazoline

xylometazoline (0.1 % solution, 3 drops, 0.15 mg) in each nostril

Trial Locations (2)

CH-8091

Pulmonary Division, University Hospital Zurich, Switzerland, Zurich

Pulmonary Division, University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT00630474 - Nasal Decongestion and Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter